Skip to main content

Advertisement

Table 1 Characteristics of 234 patients with cancer and IPE

From: Prognostic assessment for patients with cancer and incidental pulmonary embolism

  % (n)+
Age
  [Median: 67 (Range: 27–91)]
Gender
 Male 59 (139)
 Female 41 (95)
Setting
 Radical/adjuvant 20 (46)
 Metastatic/incurable 80 (188)
Diagnosis
 Colorectal cancer, early 5 (12)
 Colorectal cancer, metastatic 20 (46)
 Oesophagogastric Cancer, early 7 (17)
 Oesophagogastric Cancer, metastatic 9 (21)
 Breast Cancer, Metastatic 9 (21)
 Pancreaticobiliary Cancer, Advanced 9 (21)
 NSCLC Metastatic/ SCLC * 12 (28)
 Other 29 (68)
Treatment
 Cytotoxic chemotherapy 66 (154)
 Biologic/targeted therapy ** 13 (30)
 Hormonal manipulation therapy*** 4 (10)
 Interferon 1 (2)
Risk Factors for VTE
 Recent (30d) hospitalisation 15 (36)
 Recent (30d) Surgery 2 (5)
 Indwelling CVC 15 (35)
PS
 0 45 (105)
 1/2 43 (100)
 3/4 10 (23)
 MD 3 (6)
Extent of IPE
 Bilateral 39 (91)
 Largest vessel: pulmonary artery (main, right, left) 20 (46)
 Largest vessel: lobar branch(es) 27 (63)
 Largest vessel: segmental or subsegmental 42 (99)
 Largest vessel: subsegmental branches 11 (25)
Symptoms (self reported)
 Any new symptom 42 (98)
 Worsening pre-existing symptoms 21 (49)
PESI group
 I/II 12 (29)
 III 42 (99)
 IV 37 (86)
 V 8 (20)
  1. *Extensive and limited stages, ** CD20, VEGF, EGFR, HER2 - targeted monoclonal antibodies or tyrosine kinase inhibitors., *** Tamoxifen, aromatase inhibitors, antiandrogen, GnRH
  2. + percentages rounded for simplicity, may not add up to 100